Novartis AG
Symbol: NVS (NYSE)
122.92
▲ (0.52%) 0.630
Company Description:
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Key Stats
- Today's Open: $123.34
- Today's High: $123.492
- Today's Low: $122.647
- Today's Volume: 1.28M
- Yesterday Close: $122.29
- Yesterday High: $122.76
- Yesterday Low: $121.675
- Yesterday Volume: 1.41M
- Last Min Volume: 2
- Last Min High: $122.92
- Last Min Low: $122.92
- Last Min VWAP: $122.92
Company Profile
- Name: Novartis AG
- Website: https://www.novartis.com
- Listed Date: 1996-11-07
- Location: ,
- Market Status: Active
- CIK Number: 0001114448
- SIC Code:
- SIC description:
- Market Cap: $237.97B
- Round Lot: 100
- Outstanding Shares: 1.94B
- Asset Type: ADRC
RECENT FILINGS FOR NVS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | SC TO-C | View |
| 2025-08-11 | 6-K | View |
| 2025-07-17 | 6-K | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-07-17 | 6-K | View |
| 2025-06-25 | SC TO-T/A | View |
| 2025-06-23 | SC TO-T/A | View |
| 2025-06-17 | SC TO-T/A | View |
| 2025-06-02 | 6-K | View |
| 2025-05-27 | SC TO-T | View |
| 2025-05-23 | 144 | View |
| 2025-05-01 | SC TO-C | View |
| 2025-04-30 | SC TO-C | View |
| 2025-04-30 | 144 | View |
| 2025-04-29 | 6-K | View |
| 2025-04-08 | UPLOAD | View |
| 2025-04-03 | 6-K | View |
| 2025-03-31 | CORRESP | View |
| 2025-03-28 | 6-K | View |
| 2025-03-18 | UPLOAD | View |